Studies of Pancreatic Islet Mass by Positron Emission Tomography (PET)
NCT01552811 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2014-02-05
Summary
This study investigates the hypothesis that differences in beta-cell mass in patients with diabetes and healthy individuals can be monitored by the positron emission tomography (PET) tracer \[11C\]5-hydroxytryptophane.
Conditions
Sponsors & Collaborators
-
Uppsala University Hospital
lead OTHER
Principal Investigators
-
Per-Ola Carlsson, MD, PhD · Uppsala University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2013-03-31
- Completion
- 2013-03-31
Countries
- Sweden
Study Locations
More Related Trials
-
Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease
NCT00949403 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Fibro-inflammatory Progression From Acute to Chronic Pancreatitis
NCT03853447 ·Status: RECRUITING
-
Diagnosis of Fatty Pancreas by FibroScan
NCT07255989 ·Status: COMPLETED ·Phase: NA
-
Metabolic Associated Fatty Liver Disease and Pancreatic Steatosis in Obese Versus Lean Chronic Hepatitis B Patients
NCT07175688 ·Status: COMPLETED
-
A Prospective Study of ¹⁸F-DFA PET Imaging for the Assessment of Liver Injury
NCT07050550 ·Status: RECRUITING
-
Post-ERCP Pancreatitis Severity Indication (PEPSI) Study
NCT03075592 ·Status: COMPLETED
-
Establishment and Verification of Pancreatic Volume Formula Based on Imaging
NCT05410795 ·Status: UNKNOWN
-
The Diagnosis of Chronic Pancreatitis
NCT01059669 ·Status: UNKNOWN
-
Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)
NCT01116804 ·Status: COMPLETED ·Phase: PHASE1
-
Diagnostic Prediction of Pancreatic Masses
NCT06724055 ·Status: COMPLETED
-
Osteopontin as a Biomarker in Pancreatitis
NCT05882500 ·Status: COMPLETED
-
Serum Parameter Prior and After EUS-guided Fine Needle Aspiration of the Pancreas
NCT02397993 ·Status: UNKNOWN
-
Contrast-enhanced Ultrasound and Pancreatic Lesions
NCT05977777 ·Status: UNKNOWN ·Phase: NA
-
Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions
NCT04324294 ·Status: RECRUITING ·Phase: PHASE1
-
Hepatocellular Carcinoma Imaging Using PSMA PET/CT
NCT05095519 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Determination of Insulin-stimulated Hepatic Glucose Uptake by PET-CT Measurements
NCT04938544 ·Status: UNKNOWN
-
Observational and Prospective Study of Hepatic Steatosis and Related Risk Factors Using Ultrasound and Artificial Intelligence
NCT06103175 ·Status: ACTIVE_NOT_RECRUITING
-
Diagnostic and Evaluation of Hepato-pancreatico-biliary Disease With MRI
NCT04701567 ·Status: UNKNOWN
-
Mri and Ultrasound Elastography in Pancreatic Masses
NCT06895655 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis
NCT07291141 ·Status: RECRUITING
-
Establishment of Clinical Staging of Chronic Pancreatitis Based on Histopathology of Pancreatic Duct Biopsy
NCT05352932 ·Status: UNKNOWN
-
Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis
NCT02973516 ·Status: COMPLETED ·Phase: PHASE2
-
Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis
NCT03961516 ·Status: COMPLETED
-
Effect of Fatty Liver on TCA Cycle Flux and the Pentose Phosphate Pathway
NCT03480594 ·Status: COMPLETED
-
Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids
NCT07167251 ·Status: RECRUITING